Health
From The Report: Oman 2019
View in Online Reader

In recent decades there has been a major improvement in the quality of health care in Oman. Rising living standards have greatly reduced the impact of contagious diseases, though the high rates of non-communicable diseases – common among many GCC countries – continue to climb. Despite feeling the impact of the fiscal austerity caused by low oil prices, the country’s health sector is poised to resume growth, aided by the expected introduction of mandatory health insurance for expatriates.

Articles from this Chapter

Overview

Medical benefits: The long-term planning document Health Vision 2050 focuses on providing higher-quality services
OBG
plus

In recent decades there has been a major improvement in the quality of health care in Oman. Rising living standards have greatly reduced the impact of contagious diseases, though the high rates of non-communicable diseases (NCDs), common among many GCC countries, continue to climb. Despite feeling the impact of the fiscal austerity caused by low oil prices, the country’s health sector is poised to resume growth, aided by the expected introduction of mandatory health insurance for expatriates. Structure…

Overview

Promoting pharmaceuticals: As health care provision expands, demand for both local and imported pharmaceutical products is rising
OBG
plus

In recent decades, the pharmaceutical market has expanded its geographical reach. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018. Even in the most newly opened markets, drug companies have seen growth: forecasts for Myanmar, for instance, indicate that pharmaceuticals could quickly grow into a $1bn industry. As governments and companies continue to take note of this high-potential sector, both are pursuing development…

Overview

Promoting pharmaceuticals: As health care provision expands, demand for both local and imported pharmaceutical products is rising
OBG
plus

In recent decades, the pharmaceutical market has expanded its geographical reach. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018. Even in the most newly opened markets, drug companies have seen growth: forecasts for Myanmar, for instance, indicate that pharmaceuticals could quickly grow into a $1bn industry. As governments and companies continue to take note of this high-potential sector, both are pursuing development…